SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-016595
Filing Date
2019-08-13
Accepted
2019-08-13 17:16:47
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20190630_10q.htm 10-Q 600261
2 EXHIBIT 31.1 ex_154367.htm EX-31.1 13298
3 EXHIBIT 31.2 ex_154368.htm EX-31.2 13291
4 EXHIBIT 32.1 ex_154369.htm EX-32.1 4881
5 EXHIBIT 32.2 ex_154370.htm EX-32.2 5339
12 image02.jpg GRAPHIC 36601
  Complete submission text file 0001437749-19-016595.txt   3590521

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dmac-20190630.xml EX-101.INS 631616
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20190630.xsd EX-101.SCH 49416
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20190630_cal.xml EX-101.CAL 33675
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20190630_def.xml EX-101.DEF 300663
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20190630_lab.xml EX-101.LAB 248515
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20190630_pre.xml EX-101.PRE 324308
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 191021750
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1